drugset / Trial / NCT00888290

Sodium Bicarbonate Supplementation in Chronic Kidney Disease Evaluation of Dose Response, Safety and Beneficial Effects

NCT00888290

Phase 2/3 Completed 20 enrolled Albert Einstein College of Medicine
Non-randomizedSequentialSingle-blindTreatment

Summary

This study will enroll 25 patients with kidney disease to evaluate the effects of different doses of sodium bicarbonate (baking soda) on levels of bicarbonate in the blood, kidney function and muscle strength. The investigators will also evaluate safety and tolerability of different doses.

Timeline

Start
2009-03
Primary completion
2010-05
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator sodium bicarbonate Diagnostic / imaging agent 0.3 meq Oral
Comparator sodium bicarbonate Diagnostic / imaging agent 0.6 meq Oral
Comparator sodium bicarbonate Diagnostic / imaging agent 1 meq Oral